| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |